Nippon Steel plans to sell its 50% stake in the Calvert joint venture to ArcelorMittal for $1, contingent on the completion of its acquisition of U.S. Steel. The move aims to address antitrust concerns.
Nippon Steel Corporation has announced its intention to sell its 50% stake in the AM/NS Calvert joint venture in Alabama to ArcelorMittal for $1. This decision is contingent upon the successful acquisition of United States Steel Corporation by Nippon Steel, a deal valued at $14 billion. The sale is part of Nippon Steel's strategy to address potential antitrust issues that could arise from the acquisition.
The Calvert plant, a joint venture between Nippon Steel and ArcelorMittal, is a significant player in the North American steel market, producing 4.7 million metric tons of steel sheets annually, primarily for the automotive industry. Despite the plant's profitability, Nippon Steel is prioritizing the acquisition of U.S. Steel, which boasts a larger production capacity of nearly 16 million tons of crude steel annually.
The transaction is designed to expedite regulatory approval from U.S. authorities, as the Committee on Foreign Investment in the United States (CFIUS) has extended its review of the acquisition until the end of December. Political figures, including U.S. Vice President Kamala Harris and former President Donald Trump, have expressed opposition to the deal, advocating for U.S. Steel to remain under American ownership.
Nippon Steel anticipates a consolidated loss of approximately 230 billion yen ($1.55 billion) from the sale of its stake in the Calvert plant. However, if the acquisition of U.S. Steel does not proceed, the sale will not be finalized, and there will be no impact on Nippon Steel's earnings.
ArcelorMittal, the world's leading steel and mining company, has agreed to the purchase to alleviate regulatory concerns. The company will also inject cash and forgive loans amounting to around $900 million as part of the transaction. The agreement underscores the strategic maneuvers within the global steel industry as companies navigate complex regulatory landscapes and competitive pressures.
Party City, a leading retailer in the party supplies industry, has filed for bankruptcy and announced the closure of all its stores, marking the end of nearly 40 years in business.
Honda and Nissan are in talks for a potential merger to address financial struggles and enhance competitiveness in the electric vehicle market.
Google has proposed to loosen its search engine agreements with companies like Apple to address antitrust concerns, while the US government pushes for more drastic measures.
The US FDA has approved Novo Nordisk's Alhemo, a groundbreaking treatment for hemophilia A and B with inhibitors, marking a significant advancement in hemophilia care.
The US FDA has declined to approve Lexicon Pharmaceuticals' Zynquista as an add-on treatment for type 1 diabetes and chronic kidney disease, prompting the company to shift focus to other drug candidates.
Sarepta Therapeutics Inc. has secured a $115.2 million verdict against Nippon Shinyaku Co. Ltd. for patent infringement related to its Duchenne muscular dystrophy drug, Vyondys 53.
A US jury remains deadlocked in the high-stakes trial between Arm Holdings and Qualcomm over a licensing dispute involving Nuvia's chip designs, with deliberations ongoing.
Netflix has acquired the exclusive U.S. broadcasting rights for the FIFA Women's World Cup in 2027 and 2031, marking a significant move into live sports for the streaming giant.
Carnival Corporation & plc has reported record earnings for 2024, surpassing guidance and setting a positive outlook for 2025 with expected earnings growth and strong booking volumes.
United States Steel Corporation's stock has taken a hit following a weaker-than-expected fourth-quarter outlook, with projected losses and challenges in the steel market.